Elizabeth M. Marlowe
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus 9
- Viral gastroenteritis research and epidemiology 6
- SARS-CoV-2 detection and testing 5
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing 17
- Microbiology top 5%
- Reproductive tract infections research 9
- Epidemiology top 5%
- Infective Endocarditis Diagnosis and Management 6
- Molecular Medicine top 10%
-
- Syphilis Diagnosis and Treatment 6
-
- Streptococcal Infections and Treatments 5
- Co-authors
- Susan Novak-WeekleyAlice S. WeissfeldJim NomuraRaina M. MaierMark L. BrusseauSusan NovakPaula H. VanceJohn M. Miller
- Journals
- Environmental Science & Technology (1 paper)PLoS ONE (1 paper)Journal of Clinical Microbiology (15 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Elizabeth M. Marlowe
44 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 111
- Infectious Diseases 775
- Clinical Biochemistry 202
- Microbiology 143
- Epidemiology 690
- Molecular Medicine 45
Countries citing papers authored by Elizabeth M. Marlowe
This map shows the geographic impact of Elizabeth M. Marlowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth M. Marlowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth M. Marlowe more than expected).
Fields of papers citing papers by Elizabeth M. Marlowe
This network shows the impact of papers produced by Elizabeth M. Marlowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth M. Marlowe. The network helps show where Elizabeth M. Marlowe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elizabeth M. Marlowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 15 | |
| 5 | 2021 | 14 | |
| 6 | 2021 | 72 | |
| 7 | 2021 | 1 | |
| 8 | 2020 | 11 | |
| 9 | 2019 | 6 | |
| 10 | 2019 | 18 | |
| 11 | 2019 | 12 | |
| 12 | 2019 | 0 | |
| 13 | 2017 | 1 | |
| 14 | 2016 | 24 | |
| 15 | 2015 | 34 | |
| 16 | 2013 | 40 | |
| 17 | 2011 | 10 | |
| 18 | 2002 | 9 | |
| 19 | 2002 | 27 | |
| 20 | 1997 | 4 |
About Elizabeth M. Marlowe
Elizabeth M. Marlowe is a scholar working on Clinical Biochemistry, Microbiology and Infectious Diseases, having authored 48 papers that have together received 1.3k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (17 papers), Reproductive tract infections research (9 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Syphilis Diagnosis and Treatment (6 papers), Viral gastroenteritis research and epidemiology (6 papers), Infective Endocarditis Diagnosis and Management (6 papers), Streptococcal Infections and Treatments (5 papers) and SARS-CoV-2 detection and testing (5 papers). The work is most often cited by research in Infectious Diseases (775 citations), Clinical Biochemistry (202 citations) and Microbiology (143 citations). Elizabeth M. Marlowe has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Susan Novak-Weekley, Alice S. Weissfeld, Jim Nomura, Raina M. Maier, Mark L. Brusseau, Susan Novak, Paula H. Vance, John M. Miller, Masae Kawamura and Mark Pandori. Their work appears in journals such as Environmental Science & Technology, PLoS ONE and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.